Navigation Links
The State of Spinal Cord Injury Grand Rounds
Date:4/12/2013

WEST ORANGE, N.J.The State of Spinal Cord Injury: Latest News on Clinical Trials of Interventions to Promote Neurological Recovery will be held on Wednesday, April 17, 2013, from 4:30 to 6:30 p.m., at Kessler Conference Center1199 Pleasant Valley Way, West Orange, N.J. This special Grand Rounds is presented by the Northern New Jersey Spinal Cord Injury System (NNJSCIS) and the Spinal Cord Injury Project of the W. M. Keck Center for Collaborative Neuroscience at Rutgers, The State University of New Jersey. The NNJSCIS is a collaborative effort between Kessler Foundation, Kessler Institute for Rehabilitation and the University of Medicine and Dentistry of New Jersey (UMDNJ).

Speakers Steven Kirshblum, M.D., of Kessler Institute, and Wise Young, M.D., Ph.D., of the Keck Center, will discuss recent and ongoing clinical trials to improve recovery and quality of life in individuals with spinal cord injury (SCI).

Dr. Kirshblum is Medical Director and Director of SCI Services at Kessler Institute for Rehabilitation and Professor in the Department of Physical Medicine and Rehabilitation at UMDNJ-New Jersey Medical School (NJMS). He also serves as Program Director for the Spinal Cord Medicine Fellowship, and Co-Project Director of the NNJSCIS. Internationally recognized as an expert in SCI, he has delivered 400 national and international presentations, written and co-authored more than 100 articles in peer-reviewed publications and has completed over 25 book chapters, 60 abstracts and monographs on his research interests and education issues related to SCI. Dr. Kirshblum is also the editor of the textbook, Spinal Cord Medicine.

Dr. Young is the Founding Director of the Keck Center, Richard H. Shindell Chair in Neuroscience and Professor II in the Department of Cell Biology & Neuroscience at Rutgers University. He developed the first standardized rat SCI model used worldwide for testing therapies, formed the first consortium funded by the Natio
'/>"/>

Contact: Lauren Scrivo
LScrivo@KesslerFoundation.org
973-768-6583
Kessler Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. First genetic factor in prostate cancer prognosis identified
2. Landmark study describes prostate cancer metastasis switch
3. Genetic analysis saves major apple-producing region of Washington state
4. Statement by WCS president and CEO on historic CITES ruling
5. Wayne State vision restoration technology receives Notice of Allowance for US patent app
6. Wayne State study shows airborne dust in urban areas impacts lead levels in children
7. Wayne State University researchers techniques enable more, faster testing of biological liquids
8. Cancer risk for African-American women with benign breast disease factors Wayne State finds
9. Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office
10. Iowa State computer, electrical engineers working to help biologists cope with big data
11. Thomas Jefferson University researchers discover new pathways that drive metastatic prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2015)... 2015 Research and ... of the  "Genetic Testing Market Outlook 2018" ... , ,A recent report, Genetic Testing Market ... the current and future genetic testing market. ... working principles and types are covered in ...
(Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
(Date:5/8/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leading ... the executive management team will present at the following investor ... Telecom Conference Date: May 18, 2015 Time: 10:40am ... Cowen and Company Technology, Media & ... The New York Palace Hotel, New York, NY ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Synaptics to Present at Upcoming Investor Conferences 2
... ( www.ucr.edu ) The lab of a ... was named on Tuesday, April 3 after Innovation Economy ... research focused on using mobile devices, such as cell ... The technology being developed by Nosang Myung, professor and ...
... 30 millionth species occurrence record last week, making it ... animals and fungi. The Atlas, a collaboration between ... and Southern Cross Universities and the Commonwealth Government, reached ... Birdlife Australia were incorporated. Some of these records come ...
... A new gene that causes early-onset of Alzheimer,s disease has ... the Insert unit 1079 "Genetics of cancer and neuropsychiatric diseases" ... of 5 of 14 patients suffering from the disease, mutations ... production of a peptide involved in Alzheimer,s disease. The results ...
Cached Biology News:Using cell phones to detect harmful airborne substances 217th century Dutch explorers help the Atlas reach a major milestone -- 30 million records 2A new gene thought to be the cause in early-onset forms of Alzheimer's disease 2
(Date:5/22/2015)... , May 22, 2015 According ... Product (1D & 2D Gel Electrophoresis, Agarose & Polyacrylamide ... Reagents, Informatics), by Application & by End User - ... Market is expected to reach around $1.98 Billion by ... period 2015 to 2020. Browse 226 ...
(Date:5/22/2015)... 2015 Baylor Research Institute (BRI) at ... Research Institute (TGen) in Phoenix, AZ ... early detection and treatments for patients with a broad range ... lead to new clinical trials and access to technology to ... from bench to bedside across Baylor Scott & ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 uBiome, ... announced a partnership with PicnicHealth, a healthcare company ... Participants diagnosed with Inflammatory Bowel Disease (IBD) will ... a complementary uBiome research kit. Both companies were ... , For more information on this ...
Breaking Biology Technology:Electrophoresis Market Worth $1.98 Billion by 2020 2Electrophoresis Market Worth $1.98 Billion by 2020 3Electrophoresis Market Worth $1.98 Billion by 2020 4Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4Specialty Pharmacy Times Joins BPA Worldwide 2uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3
... Health Care (IHC) have announced a plan to ... adoption of electronic health records among U.S. health-care providers. ... Information and Management Systems Society (HIMSS) meeting in Dallas ... knowledge that IHC has gathered over the years and ...
... or process, having the next big thing is not ... marketplace, a mid-sized firm occupying several hard-won niches, or ... your success, says Tom Miller, an intellectual property lawyer ... a recent presentation to eInnovate, a Milwaukee-based technology forum, ...
... Small Tree Communications , a niche hardware ... a $445,000 funding round from Chippewa Valley Angel Investors ... to grow our business faster by getting our products to ... "It'll allow us to get office space and equipment, and ...
Cached Biology Technology:GE and Intermountain want to streamline nationwide patient data 2Protect your intellectual property before it's too late 2Protect your intellectual property before it's too late 3Chippewa Valley angels invest in network hardware company 2Chippewa Valley angels invest in network hardware company 3
Mouse monoclonal [SPM302] to BCAR1, prediluted ( Abpromise for all tested applications). entrezGeneID: 9564 SwissProtID: P56945...
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
Rabbit polyclonal to Myosin VIIa (rating: *****) ( Abpromise for all tested applications). entrezGeneID: 4647 SwissProtID: Q13402...
Mouse monoclonal [6E10] to LAP2 ( Abpromise for all tested applications). entrezGeneID: 7112 SwissProtID: P42166...
Biology Products: